A New Fast Phasing Method Based On Haplotype Subtraction

Evelina Mocci, Marija Debeljak, Alison Klein, James Eshleman

Research output: Contribution to journalArticle

Abstract

We developed a novel phasing approach, based solely on molecules and genotype frequency, that does not rely on inference of new alleles. We initiated the project because of errors that were detected in the phased 1000 Genomes Project data. The algorithm first combined identical genotypes into clusters and ranked them by descending frequency. Using alleles defined in homozygotes, it combined them to produce expected genotypes that were dismissed and subtracted them from remaining genotypes to define additional new putative alleles. Putative alleles had to be confirmed by identifying them in independent genotypes, and the process was iterated until all alleles were identified. The new approach was validated using single-molecule sequencing of eight loci, 145 (8 to 35 per locus) alleles were identified, and an average 98.2% (range, 95.0% to 99.9%) of 1000 genome individuals at these loci were explained. The accuracy of the new method was compared with that from PHASE and SHAPEIT2 to the experimentally determined genotypes based on single-molecule sequencing. Our method was comparable to PHASE and SHAPEIT2 in accuracy but was, on average, 14.6- and 10.8-fold faster, respectively.

Original languageEnglish (US)
Pages (from-to)427-436
Number of pages10
JournalJournal of Molecular Diagnostics
Volume21
Issue number3
DOIs
StatePublished - May 1 2019

Fingerprint

Haplotypes
Alleles
Genotype
Genome
Homozygote

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

A New Fast Phasing Method Based On Haplotype Subtraction. / Mocci, Evelina; Debeljak, Marija; Klein, Alison; Eshleman, James.

In: Journal of Molecular Diagnostics, Vol. 21, No. 3, 01.05.2019, p. 427-436.

Research output: Contribution to journalArticle

@article{89c6674d398d494d847ac43d4d4f4105,
title = "A New Fast Phasing Method Based On Haplotype Subtraction",
abstract = "We developed a novel phasing approach, based solely on molecules and genotype frequency, that does not rely on inference of new alleles. We initiated the project because of errors that were detected in the phased 1000 Genomes Project data. The algorithm first combined identical genotypes into clusters and ranked them by descending frequency. Using alleles defined in homozygotes, it combined them to produce expected genotypes that were dismissed and subtracted them from remaining genotypes to define additional new putative alleles. Putative alleles had to be confirmed by identifying them in independent genotypes, and the process was iterated until all alleles were identified. The new approach was validated using single-molecule sequencing of eight loci, 145 (8 to 35 per locus) alleles were identified, and an average 98.2{\%} (range, 95.0{\%} to 99.9{\%}) of 1000 genome individuals at these loci were explained. The accuracy of the new method was compared with that from PHASE and SHAPEIT2 to the experimentally determined genotypes based on single-molecule sequencing. Our method was comparable to PHASE and SHAPEIT2 in accuracy but was, on average, 14.6- and 10.8-fold faster, respectively.",
author = "Evelina Mocci and Marija Debeljak and Alison Klein and James Eshleman",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.jmoldx.2018.12.004",
language = "English (US)",
volume = "21",
pages = "427--436",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "3",

}

TY - JOUR

T1 - A New Fast Phasing Method Based On Haplotype Subtraction

AU - Mocci, Evelina

AU - Debeljak, Marija

AU - Klein, Alison

AU - Eshleman, James

PY - 2019/5/1

Y1 - 2019/5/1

N2 - We developed a novel phasing approach, based solely on molecules and genotype frequency, that does not rely on inference of new alleles. We initiated the project because of errors that were detected in the phased 1000 Genomes Project data. The algorithm first combined identical genotypes into clusters and ranked them by descending frequency. Using alleles defined in homozygotes, it combined them to produce expected genotypes that were dismissed and subtracted them from remaining genotypes to define additional new putative alleles. Putative alleles had to be confirmed by identifying them in independent genotypes, and the process was iterated until all alleles were identified. The new approach was validated using single-molecule sequencing of eight loci, 145 (8 to 35 per locus) alleles were identified, and an average 98.2% (range, 95.0% to 99.9%) of 1000 genome individuals at these loci were explained. The accuracy of the new method was compared with that from PHASE and SHAPEIT2 to the experimentally determined genotypes based on single-molecule sequencing. Our method was comparable to PHASE and SHAPEIT2 in accuracy but was, on average, 14.6- and 10.8-fold faster, respectively.

AB - We developed a novel phasing approach, based solely on molecules and genotype frequency, that does not rely on inference of new alleles. We initiated the project because of errors that were detected in the phased 1000 Genomes Project data. The algorithm first combined identical genotypes into clusters and ranked them by descending frequency. Using alleles defined in homozygotes, it combined them to produce expected genotypes that were dismissed and subtracted them from remaining genotypes to define additional new putative alleles. Putative alleles had to be confirmed by identifying them in independent genotypes, and the process was iterated until all alleles were identified. The new approach was validated using single-molecule sequencing of eight loci, 145 (8 to 35 per locus) alleles were identified, and an average 98.2% (range, 95.0% to 99.9%) of 1000 genome individuals at these loci were explained. The accuracy of the new method was compared with that from PHASE and SHAPEIT2 to the experimentally determined genotypes based on single-molecule sequencing. Our method was comparable to PHASE and SHAPEIT2 in accuracy but was, on average, 14.6- and 10.8-fold faster, respectively.

UR - http://www.scopus.com/inward/record.url?scp=85064548663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064548663&partnerID=8YFLogxK

U2 - 10.1016/j.jmoldx.2018.12.004

DO - 10.1016/j.jmoldx.2018.12.004

M3 - Article

C2 - 30872187

AN - SCOPUS:85064548663

VL - 21

SP - 427

EP - 436

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 3

ER -